Back to top
more

HealthEquity (HQY)

(Delayed Data from NSDQ)

$98.82 USD

98.82
666,765

+1.62 (1.67%)

Updated Nov 8, 2024 03:59 PM ET

After-Market: $98.64 -0.18 (-0.18%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (145 out of 250)

Industry: Medical Services

Zacks News

Here's Why You Should Hold on to IDEXX (IDXX) Stock for Now

Robust domestic and international performances by the CAG arm are driving IDEXX's (IDXX) fourth-quarter top line.

Tandem Diabetes (TNDM) to Offer Insulin Delivery With Smartphone

Tandem Diabetes' (TNDM) t:connect is the first-ever app on both iOS and Android operating systems to receive FDA clearance for insulin delivery from a personal smartphone.

OPKO's (OPK) NGENLA to Offer GHD Treatment in European Union

OPKO's (OPK) marketing authorization for NGENLA in the European Union stands to benefit children and adolescents affected by growth hormone deficiency.

Here's Why You Should Hold on to Thermo Fisher (TMO) Stock Now

Investors are optimistic about Thermo Fisher's (TMO) better-than-expected fourth-quarter results and impressive COVID-19 response-related revenues.

HealthEquity (HQY) Up 10.3% Since Last Earnings Report: Can It Continue?

HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

New Strong Sell Stocks for December 21st

BLBD, CBRL, HQY, LE and PHX have been added to the Zacks Rank #5 (Strong Sell) List on December 21, 2021.

New Strong Sell Stocks for December 10th

AVAV, HQY, MESA, SWK, and CGNX have been added to the Zacks Rank #5 (Strong Sell) List on December 10, 2021.

Here's Why You Should Hold on to Align Technology (ALGN) Now

Investors are optimistic about Align Technology's (ALGN) better-than-expected results and growing uptake of iTero scanners in the third quarter of fiscal 2021.

Medtronic (MDT) Gets Health Canada License for Hugo RAS System

The receipt of the Health Canada license for Medtronic's (MDT) Hugo RAS System is likely to enhance accessibility to robotic-assisted surgery in Canada.

HealthEquity (HQY) Q3 Earnings Beat, FY 2022 View Lowered

HealthEquity (HQY) witnesses solid growth in HSAs besides recording robust Interchange revenues in the third quarter of fiscal 2022.

Why Seasoned Investors are Retaining Select Medical (SEM) Stock

Select Medical (SEM) is focused on making strategic acquisitions to boost its business through inorganic growth.

Acadia (ACHC) & Orlando Health Form JV, Boosts Presence

Acadia Healthcare Company (ACHC) expects to take on Orlando Health South Seminole Hospital's management responsibilities of the behavioral health program.

Earnings Preview: HealthEquity (HQY) Q3 Earnings Expected to Decline

HealthEquity (HQY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

After Plunging 13.3% in 4 Weeks, Here's Why the Trend Might Reverse for HealthEquity (HQY)

HealthEquity (HQY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

PINC or HQY: Which Is the Better Value Stock Right Now?

PINC vs. HQY: Which Stock Is the Better Value Option?

PINC vs. HQY: Which Stock Should Value Investors Buy Now?

PINC vs. HQY: Which Stock Is the Better Value Option?

HealthEquity (HQY) Down 1.7% Since Last Earnings Report: Can It Rebound?

HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Company News for Sep 10, 2021

Companies In The News Are: LULU, RH, HQY, MRNA

HealthEquity (HQY) Q2 Earnings & Revenues Beat Estimates

HealthEquity (HQY) witnesses solid growth in HSAs and records robust Interchange revenues in the second quarter of fiscal 2022.

HealthEquity (HQY) Tops Q2 Earnings and Revenue Estimates

HealthEquity (HQY) delivered earnings and revenue surprises of 11.11% and 2.12%, respectively, for the quarter ended July 2021. Do the numbers hold clues to what lies ahead for the stock?

AMN Healthcare (AMN) Hits 52-Week High: What's Behind It?

Investors are optimistic about AMN Healthcare's (AMN) broad array of services.

Zacks Industry Outlook Highlights: HealthEquity, Progyny, Surgery Partners, ModivCare and Agiliti

Zacks Industry Outlook Highlights: HealthEquity, Progyny, Surgery Partners, ModivCare and Agiliti

Analysts Estimate HealthEquity (HQY) to Report a Decline in Earnings: What to Look Out for

HealthEquity (HQY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Urmimala Biswas headshot

5 Medical Services Stocks Countering Industry Headwinds

The Zacks Medical - Services industry is growing on digital healthcare adoption. HQY, PGNY, SGRY, MODV, and AGTI are set to gain the most. However, falling healthcare spending may disrupt the trend.

PINC or HQY: Which Is the Better Value Stock Right Now?

PINC vs. HQY: Which Stock Is the Better Value Option?